有趣的是，Infigratinib最初于2021年获批用于胆管癌，后因适应症开发策略调整而主动撤回。如今，其有望在ACH赛道迎来“第二春”。基于其疗效和口服便利性，BridgeBio在今年的JPM大会上预测，该药Infigratinib将占据ACH治疗市场50%以上的份额。
Жители Санкт-Петербурга устроили «крысогон»17:52
，推荐阅读Line官方版本下载获取更多信息
Netflix is reportedly looking into a bid for Warner Bros. Discovery，推荐阅读safew官方下载获取更多信息
The answers surprised me. Weekend commits are actually less likely to introduce vulnerabilities, but they take 45% longer to fix. Intel contributes the most bugs because they contribute the most code. And 117 "super-reviewers" catch bugs nearly twice as fast as everyone else.